File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial
  • Basic View
  • Metadata View
  • XML View
TitleTelbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial
 
AuthorsLai, CL
Gane, E
Liaw, YF
Thongsawat, S
Wang, YM
Chen, Y
Heathcote, J
Rasenack, J
Bzowej, N
Naoumov, N
Chao, G
Fielman, B
Brown, N
and the GLOBE Study Group, .
 
Issue Date2005
 
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
 
CitationHepatology, v. 42 n. Suppl 1, p. 748A [How to Cite?]
 
ISSN0270-9139
2012 Impact Factor: 12.003
2012 SCImago Journal Rankings: 4.260
 
DC FieldValue
dc.contributor.authorLai, CL
 
dc.contributor.authorGane, E
 
dc.contributor.authorLiaw, YF
 
dc.contributor.authorThongsawat, S
 
dc.contributor.authorWang, YM
 
dc.contributor.authorChen, Y
 
dc.contributor.authorHeathcote, J
 
dc.contributor.authorRasenack, J
 
dc.contributor.authorBzowej, N
 
dc.contributor.authorNaoumov, N
 
dc.contributor.authorChao, G
 
dc.contributor.authorFielman, B
 
dc.contributor.authorBrown, N
 
dc.contributor.authorand the GLOBE Study Group, .
 
dc.date.accessioned2010-09-25T19:41:31Z
 
dc.date.available2010-09-25T19:41:31Z
 
dc.date.issued2005
 
dc.identifier.citationHepatology, v. 42 n. Suppl 1, p. 748A [How to Cite?]
 
dc.identifier.hkuros121904
 
dc.identifier.issn0270-9139
2012 Impact Factor: 12.003
2012 SCImago Journal Rankings: 4.260
 
dc.identifier.issueSuppl 1
 
dc.identifier.openurl
 
dc.identifier.spage748
 
dc.identifier.urihttp://hdl.handle.net/10722/101239
 
dc.identifier.volume, v. 42 n. Suppl 1
 
dc.languageeng
 
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
 
dc.relation.ispartofHepatology
 
dc.rightsHepatology. Copyright © John Wiley & Sons, Inc.
 
dc.titleTelbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Lai, CL</contributor.author>
<contributor.author>Gane, E</contributor.author>
<contributor.author>Liaw, YF</contributor.author>
<contributor.author>Thongsawat, S</contributor.author>
<contributor.author>Wang, YM</contributor.author>
<contributor.author>Chen, Y</contributor.author>
<contributor.author>Heathcote, J</contributor.author>
<contributor.author>Rasenack, J</contributor.author>
<contributor.author>Bzowej, N</contributor.author>
<contributor.author>Naoumov, N</contributor.author>
<contributor.author>Chao, G</contributor.author>
<contributor.author>Fielman, B</contributor.author>
<contributor.author>Brown, N</contributor.author>
<contributor.author>and the GLOBE Study Group, .</contributor.author>
<date.accessioned>2010-09-25T19:41:31Z</date.accessioned>
<date.available>2010-09-25T19:41:31Z</date.available>
<date.issued>2005</date.issued>
<identifier.citation>Hepatology, v. 42  n. Suppl 1, p. 748A</identifier.citation>
<identifier.issn>0270-9139</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/101239</identifier.uri>
<language>eng</language>
<publisher>John Wiley &amp; Sons, Inc. The Journal&apos;s web site is located at http://www.hepatology.org/</publisher>
<relation.ispartof>Hepatology</relation.ispartof>
<rights>Hepatology. Copyright &#169; John Wiley &amp; Sons, Inc.</rights>
<title>Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0270-9139&amp;volume=42 &amp;issue=Suppl 1&amp;spage=748A&amp;epage=&amp;date=2005&amp;atitle=Telbivudine+(LdT)+vs.+lmivudine+for+chronic+Hepatitis+B:+First-year+results+from+the+international+phase+III+GLOBE+trial</identifier.openurl>
<identifier.hkuros>121904</identifier.hkuros>
<identifier.volume>, v. 42  n. Suppl 1</identifier.volume>
<identifier.issue>Suppl 1</identifier.issue>
<identifier.spage>748</identifier.spage>
</item>